Login / Signup

Exploring polypharmacy phenomenon in newly diagnosed relapsing-remitting multiple sclerosis: a cohort ambispective single-centre study.

Aurora ZanghìEmanuele D'AmicoSalvatore Lo FermoFrancesco Patti
Published in: Therapeutic advances in chronic disease (2021)
Polypharmacy was more common in older RRMS patients with high BMI.
Keyphrases
  • multiple sclerosis
  • newly diagnosed
  • white matter
  • body mass index
  • physical activity
  • adverse drug
  • emergency department
  • disease activity
  • electronic health record
  • drug induced